Knowledge graph visualization and retrospective analysis of genetic research on pediatric cardiomyopathy (2000–2024)
-
By
-
Xiaohua Han
-
Feng Wang
-
Guifang Wang
-
June 2, 2026
-
Clinical Scorecard: Visualization of Knowledge Graphs and Retrospective Assessment of Genetic Studies in Pediatric Cardiomyopathy (2000–2024)
At a Glance
| Category | Detail |
|---|
| Condition | Pediatric Cardiomyopathy |
| Key Mechanisms | Genetic abnormalities leading to myocardial dysfunction |
| Target Population | Children with cardiomyopathy |
| Care Setting | Pediatric healthcare |
Key Highlights
- Pediatric cardiomyopathy is a leading cause of heart failure and sudden cardiac death in children.
- Research has evolved from single-gene screening to precision medicine with dynamic monitoring.
- The U.S., China, and the U.K. are core publishing nations in pediatric cardiomyopathy genetics.
Guideline-Based Recommendations
Diagnosis
- Improving early screening and genetic counseling is a key priority.
Management
- Targeted management strategies are essential for affected children.
Monitoring & Follow-up
- Dynamic monitoring supports personalized risk assessment.
Risks
- Approximately 1/3 of affected children may die or require heart transplantation.
Patient & Prescribing Data
Children diagnosed with cardiomyopathy
Genetic testing technologies are crucial for diagnosis and risk assessment.
Clinical Best Practices
- Utilize multi-omics technologies for precise classification.
- Incorporate artificial intelligence in genetic testing for improved outcomes.
Related Resources & Content
